anistically but also explains a signifıcant number of observations," he says.
Methanosarcina bloomed explosively, spewing prodigious amounts of methane into the atmosphere, dramatically changing the climate as well as the chemistry of the oceans. Meanwhile, massive volcanism led nickel levels in sediments to increase abruptly. Nickel is an essential component of a key enzyme of methanogens, and the surge in availability of this metal was crucial for the Methanosarcina bloom, according to Rothman.
"The ideas presented in the Rothman paper are not unreasonable, but I think it is fanciful to think that microbes 'caused' the PT extinction," says David Bond from the University of Hull in the United Kingdom. "Maybe they played a part in the predicted volcanism-climate change-anoxia-extinction scenario, but we are still a long way from understanding the actual causes of this event." He also says that the new hypothesis provides a "highly plausible mechanism for generating observed carbon isotopic shifts." The IHR rules, which are meant "to prevent, protect against, control, and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks, and which avoid unnecessary interference with international traffıc and trade," require countries to "report certain disease outbreaks and public health events to WHO." The rules also require countries to "strengthen core surveillance and response capacities at the primary, intermediate, and national level. . . ."
The H1N1 influenza pandemic, whose initial outbreaks occurred early in 2009 fırst in Mexico and then in California, provided the fırst test of IHR 2005 and led to its fırst formal review the following year, according to IOM President Harvey Fineberg. He was one of 24 experts from as many countries who served on a World Health Assembly (WHA) committee to conduct that review. One "special challenge" for the committee was to hold its meetings open to the public, heading off criticisms that "WHO was being secretive," he says.
The WHA committee came to several key conclusions about IHR 2005, according to Fineberg. First, the new rules "helped the world be better prepared" to cope with emerging diseases, even though many countries still fall short in terms of their core capacities for dealing with such emergencies, he says. Another issue is that, although IHR 2005 rules are binding, enforcement measures are lacking and, instead, depend on what can be negotiated with or cajoled from each country.
MINITOPIC

WHO Documents Antibiotic Resistance, Polio, Ebola Outbreaks
World Health Organization (WHO) officials recently issued several reports with warnings on worldwide antibiotic resistance, a resurgence of polio, and a major outbreak of Ebola virus in West Africa:
• In April, WHO officials released a comprehensive report on antibiotic resistance, "Antimicrobial resistance: global report on surveillance," featuring data from 114 countries and providing a global overview as well as region-by-region analyses of drug resistance patterns. It calls drug resistance a "major threat to public health" and says that WHO is seeking "improved collaboration around the world to track drug resistance, measure its health and economic impacts, and design targeted solutions." WHO takes great pains not to embarrass individual countries for how well or poorly they "measure up," and this low-key approach ends up being a "core problem," Fineberg says. Although the idea of WHO helping in efforts to assess a country's capacity to deal with emerging infectious diseases "makes sense, national governments don't like it," Fukuda adds, noting that only about 20% of the countries have the appropriate capacity. "WHO is well-positioned to help with quality assessments, but we haven't found the right way to achieve the necessary political balance."
Another looming issue is how best to deal with the Convention on Biological Diversity (CBD), an international agreement from 1992 that was never intended to deal with public health issues. Nonetheless, some of its provi- 
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Freely Diffusing Topical Antifungal Agent Fixes Infected Toenails David C. Holzman
The candidate antifungal drug efına-conazole is proving effective against toenail infections. The drug diffuses relatively freely through nails and binds less strongly to keratin than do other topically applied antifungal drugs, leaving it free to fıght the fungus, according to Keita Sugiura of Kaken Pharmaceutical of Kyoto, Japan, and his collaborators. "This study suggests that . . . low keratin affınity is needed for favorable penetration and retention of antifungal activity within the nail matrix," he says. Details appeared online 21 April 2014 and will be printed in the July 2014 Antimicrobial Agents and Chemotherapy.
Because topical antifungal drugs so often fail to cure this condition, physicians sometimes prescribe oral antifungal drugs such as terbinafıne and itraconazole for some of their patients with stubborn cases of onychomycosis. However, Sugiura points out, this approach "is limited" because such drugs can damage the liver or may interact with other drugs that patients are taking. Although topically applied antifungal drugs such as ciclopirox and amorolfıne have "a favorable safety profıle," he adds, "their cure rates are considerably lower." Sugiura and his collaborators tested human nails to fınd how well the drug diffuses through keratin-rich nails. Small 16 mm 2 squares from commercially available toenail material (who knew?) were mounted in Franz diffusion cells to measure how quickly several antifungal drugs pass through that material. Efınaconazole proved speediest, racing through the mounted nail squares within the fırst day, while ciclopirox took six days and amorolfıne remained undetected, they report.
Of several drugs tested, only efına-conazole inhibited fungal growth under nails in vitro, according to Sugiura.
He and his collaborators also tested the fungicidal activity of several topical antifungal products in a fluid keratin medium that is designed to "mimic the keratin-rich environment of the nail plate and nail bed." Without a solid matrix to block the drugs, efınaconazole proved slightly more potent at killing
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Shapes and Curves; Plus Revised View of Cell-Wall Growth
The shapes of microbial species are sometimes fanciful and can be important for their survival or may mask activities that are key to physiology. Recent examples include:
• Helicosporidium, a corkscrew-shaped intracellular parasite that feeds on juvenile insects, derived from algae but, unlike Plasmodium, the parasite responsible for malaria which also derived from algae, retained most of its genes except those explicitly needed for photosynthesis, according to 
